A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Conditions: Ulcerative Colitis Interventions: Drug: Lutikizumab Matching Placebo; Drug: Lutikizumab Matching Placebo; Drug: Adalimumab Matching Placebo; Drug: Lutikizumab; Drug: Lutikizumab; Drug: Adalimumab Sponsors: AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials